Literature DB >> 17656035

Adiponectin: is it a novel treatment modality to alleviate liver injury in non-alcoholic fatty liver disease (NAFLD)?

Cem Aygun, Orhan Kocaman, Omer Senturk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17656035     DOI： 10.1016/j.mehy.2007.05.034

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN： 0306-9877            Impact factor:   1.538


× No keyword cloud information.
  1 in total

1.  Fenofibrate and PBA prevent fatty acid-induced loss of adiponectin receptor and pAMPK in human hepatoma cells and in hepatitis C virus-induced steatosis.

Authors:  Shaikh Mizanoor Rahman; Ishtiaq Qadri; Rachel C Janssen; Jacob E Friedman
Journal:  J Lipid Res       Date:  2009-06-05       Impact factor: 5.922
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.